A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

November 14, 2014

Primary Completion Date

December 11, 2015

Study Completion Date

December 11, 2015

Conditions
Asthma
Interventions
DRUG

NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler

Micronized 400 mcg budesonide+ 12 mcg formoterol fumarate along with micronized and crystalline lactose monohydrate (excipient), per capsule dispensed by single capsule inhaler, twice daily (administered once in the morning and once in the evening approximately 12 hours later).

DRUG

SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler

Unit dose containing 320 mcg budesonide and 9 mcg formoterol fumarate (as dihidrate) along with lactose monohydrate as excipient. Administered as inhalation by TURBUHALER inhaler, twice daily (once in the morning and once in the evening approximately 12 hours later)

DRUG

NEUMOTEX 400 (Budesonide 400 mcg)

Budesonide 400mcg will be administered to all the subjects twice daily, during the Run-in and Washout Periods

DRUG

Salbutamol 100 mcg pMDI

Salbutamol 100mcg will be administered as pMDI on demand, as rescue medication, throughout the entire study period until Visit 5

Trial Locations (11)

1842

GSK Investigational Site, Monte Grande

1886

GSK Investigational Site, Berazategui

1900

GSK Investigational Site, La Plata

2000

GSK Investigational Site, Rosario

GSK Investigational Site, Rosario

7600

GSK Investigational Site, Mar del Plata

C1028AAP

GSK Investigational Site, Ciudad Autónoma de Buenos Aires

B7600FZN

GSK Investigational Site, Mar del Plata

B1602DOH

GSK Investigational Site, Vicente López

B1884AAC

GSK Investigational Site, Berazategui, Buenos Aires

C1121ABE

GSK Investigational Site, Buenos Aires

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02233803 - A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma | Biotech Hunter | Biotech Hunter